Trial Profile
A phase III study of JR-401 in short stature patients with SHOX deficiency
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 13 Oct 2022
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Short stature
- Focus Therapeutic Use
- Sponsors JCR Pharmaceuticals
- 10 Jul 2018 New Source Identified and integrated Japan Pharmaceutical Information Center - Clinical Trials Information (JapicCTI-183946)
- 02 Jul 2018 Status changed from planning to recruiting, according to a JCR Pharmaceuticals media release.
- 24 May 2018 New trial record